Stay updated on Pembrolizumab Plus Lenvatinib Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Plus Lenvatinib Clinical Trial page.
Latest updates to the Pembrolizumab Plus Lenvatinib Clinical Trial page
- Check5 days agoChange DetectedResults for LEAP-005 have been posted, including ORR, DCR, PFS, and OS outcomes with definitions and time frames. The page now lists a non-randomized design and updated trial sites such as Tainan, Taiwan.SummaryDifference2%
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedPublications with LEAP-005 results were added to the Study Results section, including outcomes for the triple-negative breast cancer and ovarian cancer cohorts.SummaryDifference0.2%
- Check26 days agoChange DetectedReplaced the Santiago de Cali site entry with Cali, Valle del Cauca Department, Colombia, 760032 and added this Cali site to the study locations.SummaryDifference0.0%
- Check41 days agoChange DetectedUpdated status: from 'No Results Posted' to 'Results Submitted', indicating that results have now been submitted.SummaryDifference0.1%
- Check48 days agoChange DetectedCore content updated with a government-operating-status notice and a new version tag (v3.2.0); the old version v3.1.0 was removed.SummaryDifference1%
- Check55 days agoChange DetectedIntroduces version v3.1.0 and removes the term 'Ovarian cancer', indicating a page update with topic scope refinement.SummaryDifference0.1%
Stay in the know with updates to Pembrolizumab Plus Lenvatinib Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Plus Lenvatinib Clinical Trial page.